CVR number 15002107
Industry 32.5000 Manufacture of medical and dental instruments and supplies

HJØRRING DENTAL LABORATORIUM ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
Bankruptcy risk for industry  2.2% 2.2% 2.2% 2.2% 2.2%  
Bankruptcy risk  3.3% 3.5% 5.3% 3.3% 3.1%  
Credit score (0-100)  56 53 41 54 55  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
Net sales  0 0 0 0 0  
Gross profit  1,088 1,255 1,063 988 975  
EBITDA  9.0 73.0 -117 194 140  
EBIT  -7.0 59.0 -125 194 140  
Pre-tax profit (PTP)  -18.0 57.0 -123.0 198.0 143.8  
Net earnings  -14.0 44.0 -96.0 154.0 111.8  
Pre-tax profit without non-rec. items  -18.0 57.0 -123 198 144  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
Tangible assets total  21.0 8.0 0.0 0.0 0.0  
Shareholders equity total  158 202 105 259 371  
Interest-bearing liabilities  344 76.0 175 232 61.5  
Balance sheet total (assets)  781 724 584 722 664  
Net Debt  105 0.0 87.0 -44.0 -64.1  
 
See the entire balance sheet

Volume 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,088 1,255 1,063 988 975  
Gross profit growth  -9.0% 15.3% -15.3% -7.1% -1.3%  
Employees  3 3 3 2 2  
Employee growth %  0.0% 0.0% 0.0% -33.3% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  781 724 584 722 664  
Balance sheet change%  -2.1% -7.3% -19.3% 23.6% -8.0%  
Added value  9.0 73.0 -117.0 202.0 140.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -33 -27 -16 0 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 1.0 -1.0 1.0 2.0  

Profitability 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -0.6% 4.7% -11.8% 19.6% 14.4%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -0.9% 8.6% -18.5% 31.2% 22.0%  
ROI %  -1.3% 14.2% -34.0% 44.1% 28.2%  
ROE %  -8.5% 24.4% -62.5% 84.6% 35.5%  

Solidity 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
Equity ratio %  20.2% 27.9% 18.0% 35.9% 55.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  1,166.7%   -74.4% -22.7% -45.7%  
Gearing %  217.7% 37.6% 166.7% 89.6% 16.6%  
Net interest  0 0 0 0 0  
Financing costs %  3.2% 3.8% 1.6% 2.9% 6.1%  

Liquidity 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
Quick Ratio  1.0 1.2 1.0 1.4 2.3  
Current Ratio  1.4 1.6 1.5 1.9 3.2  
Cash and cash equivalent  239.0 76.0 88.0 276.0 125.6  

Capital use efficiency 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  176.0 243.0 151.0 297.0 407.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/5
2020
2021/5
2021
2022/5
2022
2023/5
2023
2024/5
Net sales / employee  0 0 0 0 0  
Added value / employee  3 24 -39 101 70  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  3 24 -39 97 70  
EBIT / employee  -2 20 -42 97 70  
Net earnings / employee  -5 15 -32 77 56